Glycemia and cognitive function in metabolic syndrome and coronary heart disease - PubMed (original) (raw)
Clinical Trial
Glycemia and cognitive function in metabolic syndrome and coronary heart disease
Radhika Avadhani et al. Am J Med. 2015 Jan.
Abstract
Objective: Higher hemoglobin A1c (HbA1c) is associated with lower cognitive function in type 2 diabetes. To determine whether associations persist at lower levels of dysglycemia in patients who have established cardiovascular disease, cognitive performance was assessed in the Targeting INflammation Using SALsalate in CardioVascular Disease (TINSAL-CVD) trial.
Methods: The age-adjusted relationships between HbA1c and cognitive performance measured by the Mini-Mental State Examination, Digit Symbol Substitution Test, Rey Auditory Verbal Learning Test, Trail Making Test, and Categorical Verbal Fluency were assessed in 226 men with metabolic syndrome and established stable coronary artery disease.
Results: Of the participants, 61.5% had normoglycemia, 20.8% had impaired fasting glucose, and 17.7% had type 2 diabetes. HbA1c was associated with cognitive function tests of Digit Symbol Substitution Test, Rey Auditory Verbal Learning Test, Trail Making Test, and Categorical Verbal Fluency (all P < .02), but not the Mini-Mental State Examination. In an age-adjusted model, a 1% (11 mmol/mol) higher HbA1c value was associated with a 5.9 lower Digit Symbol Substitution Test score (95% confidence interval [CI], -9.58 to -2.21; P < .0001); a 2.44 lower Rey Auditory Verbal Learning Test score (95% CI, -4.00 to -0.87; P < .0001); a 15.6 higher Trail Making Test score (95% CI, 5.73 to 25.6; P < .0001); and a 3.71 lower Categorical Verbal Fluency score (95% CI, -6.41 to -1.01; P < .02). In a multivariate model adjusting for age, education, and cardiovascular covariates, HbA1c remained associated with cognitive function tests of Rey Auditory Verbal Learning Test (R(2) = 0.27, P < .0001), Trail Making Test (R(2) = 0.18, P < .0001), and Categorical Verbal Fluency (R(2) = 0.20, P < .0001), although association with the Digit Symbol Substitution Test was reduced.
Conclusions: Higher HbA1c is associated with lower cognitive function performance scores across multiple domain tests in men with metabolic syndrome and coronary artery disease. Future studies may demonstrate whether glucose lowering within the normative range improves cognitive health.
Keywords: Cardiovascular disease; Cognitive function; Glycemia; Hemoglobin A(1c).
Copyright © 2015 Elsevier Inc. All rights reserved.
Conflict of interest statement
Conflict of interest: None
Figures
Figure 1. Association of Glycemia with Measures of Cognitive Function
Figure 1A: Mini-Mental State Exam Figure 1B: Digit Symbol Substitution Test Figure 1C: Rey Auditory Verbal Learning Test Figure 1D: Trail Making Test B Figure 1E: Categorical Verbal Fluency Figure 1 displays in the full study cohort population scatterplots showing correlation, fitted regression, and 95% confidence intervals relating Hemoglobin A1c and cognitive function tests [A] Displays the fit plot for regression of Mini-mental state examination (MMSE) and Hemoglobin A1c (HbA1c). There is no association between HbA1c and Mini-Mental State Examination score (_P_=0.07). [B] Displays the fit plot regression for Digit Symbol Substitution Test (DSST) and HbA1c. The average DSST score of a patient changes by β̂ =−7.79 units for each unit change in HbA1c (r=−0.27, P<0.0001), [C] Displays the fit plot for regression of Rey Auditory Verbal Learning Test (RAVLT) and HbA1c. The average RAVLT score of a patient changes by _β̂_= −3.44 units for each unit change in HbA1c (r=−0.27, P <0.0001). [D] Displays the fit plot for regression of Trail Making B and HbA1c, The average Trail Making B score of a patient changes by _β̂_=20.6 units for each unit change in HbA1c (r=0.27, P<0.0001) and [E] Displays the fit plot for regression of Categorical Verbal Fluency (CVF) and HbA1c. The average CVF score of a patient changes by _β̂_= −3.82 units for each unit change in HbA1c (r=−0.19, _P_=0.0042). To convert HbA1c: HbA1c(%) = [0.09148 * HbA1c (mmol/mol)] + 2.152.
Figure 1. Association of Glycemia with Measures of Cognitive Function
Figure 1A: Mini-Mental State Exam Figure 1B: Digit Symbol Substitution Test Figure 1C: Rey Auditory Verbal Learning Test Figure 1D: Trail Making Test B Figure 1E: Categorical Verbal Fluency Figure 1 displays in the full study cohort population scatterplots showing correlation, fitted regression, and 95% confidence intervals relating Hemoglobin A1c and cognitive function tests [A] Displays the fit plot for regression of Mini-mental state examination (MMSE) and Hemoglobin A1c (HbA1c). There is no association between HbA1c and Mini-Mental State Examination score (_P_=0.07). [B] Displays the fit plot regression for Digit Symbol Substitution Test (DSST) and HbA1c. The average DSST score of a patient changes by β̂ =−7.79 units for each unit change in HbA1c (r=−0.27, P<0.0001), [C] Displays the fit plot for regression of Rey Auditory Verbal Learning Test (RAVLT) and HbA1c. The average RAVLT score of a patient changes by _β̂_= −3.44 units for each unit change in HbA1c (r=−0.27, P <0.0001). [D] Displays the fit plot for regression of Trail Making B and HbA1c, The average Trail Making B score of a patient changes by _β̂_=20.6 units for each unit change in HbA1c (r=0.27, P<0.0001) and [E] Displays the fit plot for regression of Categorical Verbal Fluency (CVF) and HbA1c. The average CVF score of a patient changes by _β̂_= −3.82 units for each unit change in HbA1c (r=−0.19, _P_=0.0042). To convert HbA1c: HbA1c(%) = [0.09148 * HbA1c (mmol/mol)] + 2.152.
Figure 1. Association of Glycemia with Measures of Cognitive Function
Figure 1A: Mini-Mental State Exam Figure 1B: Digit Symbol Substitution Test Figure 1C: Rey Auditory Verbal Learning Test Figure 1D: Trail Making Test B Figure 1E: Categorical Verbal Fluency Figure 1 displays in the full study cohort population scatterplots showing correlation, fitted regression, and 95% confidence intervals relating Hemoglobin A1c and cognitive function tests [A] Displays the fit plot for regression of Mini-mental state examination (MMSE) and Hemoglobin A1c (HbA1c). There is no association between HbA1c and Mini-Mental State Examination score (_P_=0.07). [B] Displays the fit plot regression for Digit Symbol Substitution Test (DSST) and HbA1c. The average DSST score of a patient changes by β̂ =−7.79 units for each unit change in HbA1c (r=−0.27, P<0.0001), [C] Displays the fit plot for regression of Rey Auditory Verbal Learning Test (RAVLT) and HbA1c. The average RAVLT score of a patient changes by _β̂_= −3.44 units for each unit change in HbA1c (r=−0.27, P <0.0001). [D] Displays the fit plot for regression of Trail Making B and HbA1c, The average Trail Making B score of a patient changes by _β̂_=20.6 units for each unit change in HbA1c (r=0.27, P<0.0001) and [E] Displays the fit plot for regression of Categorical Verbal Fluency (CVF) and HbA1c. The average CVF score of a patient changes by _β̂_= −3.82 units for each unit change in HbA1c (r=−0.19, _P_=0.0042). To convert HbA1c: HbA1c(%) = [0.09148 * HbA1c (mmol/mol)] + 2.152.
Figure 1. Association of Glycemia with Measures of Cognitive Function
Figure 1A: Mini-Mental State Exam Figure 1B: Digit Symbol Substitution Test Figure 1C: Rey Auditory Verbal Learning Test Figure 1D: Trail Making Test B Figure 1E: Categorical Verbal Fluency Figure 1 displays in the full study cohort population scatterplots showing correlation, fitted regression, and 95% confidence intervals relating Hemoglobin A1c and cognitive function tests [A] Displays the fit plot for regression of Mini-mental state examination (MMSE) and Hemoglobin A1c (HbA1c). There is no association between HbA1c and Mini-Mental State Examination score (_P_=0.07). [B] Displays the fit plot regression for Digit Symbol Substitution Test (DSST) and HbA1c. The average DSST score of a patient changes by β̂ =−7.79 units for each unit change in HbA1c (r=−0.27, P<0.0001), [C] Displays the fit plot for regression of Rey Auditory Verbal Learning Test (RAVLT) and HbA1c. The average RAVLT score of a patient changes by _β̂_= −3.44 units for each unit change in HbA1c (r=−0.27, P <0.0001). [D] Displays the fit plot for regression of Trail Making B and HbA1c, The average Trail Making B score of a patient changes by _β̂_=20.6 units for each unit change in HbA1c (r=0.27, P<0.0001) and [E] Displays the fit plot for regression of Categorical Verbal Fluency (CVF) and HbA1c. The average CVF score of a patient changes by _β̂_= −3.82 units for each unit change in HbA1c (r=−0.19, _P_=0.0042). To convert HbA1c: HbA1c(%) = [0.09148 * HbA1c (mmol/mol)] + 2.152.
Figure 1. Association of Glycemia with Measures of Cognitive Function
Figure 1A: Mini-Mental State Exam Figure 1B: Digit Symbol Substitution Test Figure 1C: Rey Auditory Verbal Learning Test Figure 1D: Trail Making Test B Figure 1E: Categorical Verbal Fluency Figure 1 displays in the full study cohort population scatterplots showing correlation, fitted regression, and 95% confidence intervals relating Hemoglobin A1c and cognitive function tests [A] Displays the fit plot for regression of Mini-mental state examination (MMSE) and Hemoglobin A1c (HbA1c). There is no association between HbA1c and Mini-Mental State Examination score (_P_=0.07). [B] Displays the fit plot regression for Digit Symbol Substitution Test (DSST) and HbA1c. The average DSST score of a patient changes by β̂ =−7.79 units for each unit change in HbA1c (r=−0.27, P<0.0001), [C] Displays the fit plot for regression of Rey Auditory Verbal Learning Test (RAVLT) and HbA1c. The average RAVLT score of a patient changes by _β̂_= −3.44 units for each unit change in HbA1c (r=−0.27, P <0.0001). [D] Displays the fit plot for regression of Trail Making B and HbA1c, The average Trail Making B score of a patient changes by _β̂_=20.6 units for each unit change in HbA1c (r=0.27, P<0.0001) and [E] Displays the fit plot for regression of Categorical Verbal Fluency (CVF) and HbA1c. The average CVF score of a patient changes by _β̂_= −3.82 units for each unit change in HbA1c (r=−0.19, _P_=0.0042). To convert HbA1c: HbA1c(%) = [0.09148 * HbA1c (mmol/mol)] + 2.152.
Similar articles
- Relationship between baseline glycemic control and cognitive function in individuals with type 2 diabetes and other cardiovascular risk factors: the action to control cardiovascular risk in diabetes-memory in diabetes (ACCORD-MIND) trial.
Cukierman-Yaffe T, Gerstein HC, Williamson JD, Lazar RM, Lovato L, Miller ME, Coker LH, Murray A, Sullivan MD, Marcovina SM, Launer LJ; Action to Control Cardiovascular Risk in Diabetes-Memory in Diabetes (ACCORD-MIND) Investigators. Cukierman-Yaffe T, et al. Diabetes Care. 2009 Feb;32(2):221-6. doi: 10.2337/dc08-1153. Diabetes Care. 2009. PMID: 19171735 Free PMC article. Clinical Trial. - Effects of Longitudinal Glucose Exposure on Cognitive and Physical Function: Results from the Action for Health in Diabetes Movement and Memory Study.
Beavers KM, Leng I, Rapp SR, Miller ME, Houston DK, Marsh AP, Hire DG, Baker LD, Bray GA, Blackburn GL, Hergenroeder AL, Jakicic JM, Johnson KC, Korytkowski MT, Dorsten BV, Kritchevsky SB; Action for Health in Diabetes Movement and Memory Ancillary Study Research Group. Beavers KM, et al. J Am Geriatr Soc. 2017 Jan;65(1):137-145. doi: 10.1111/jgs.14478. Epub 2016 Sep 27. J Am Geriatr Soc. 2017. PMID: 27676466 Free PMC article. - Fasting Glucose Variability in Young Adulthood and Cognitive Function in Middle Age: The Coronary Artery Risk Development in Young Adults (CARDIA) Study.
Bancks MP, Carnethon MR, Jacobs DR Jr, Launer LJ, Reis JP, Schreiner PJ, Shah RV, Sidney S, Yaffe K, Yano Y, Allen NB. Bancks MP, et al. Diabetes Care. 2018 Dec;41(12):2579-2585. doi: 10.2337/dc18-1287. Epub 2018 Oct 10. Diabetes Care. 2018. PMID: 30305344 Free PMC article. - Determinants of cognitive function in individuals with type 2 diabetes mellitus: A meta-analysis.
Mansur RB, Lee Y, Zhou AJ, Carmona NE, Cha DS, Rosenblat JD, Bruins R, Kakar R, Rasgon NL, Lovshin JA, Wroolie TE, Sim K, Brietzke E, Gerstein HC, Rong C, McIntyre RS. Mansur RB, et al. Ann Clin Psychiatry. 2018 Feb;30(1):38-50. Ann Clin Psychiatry. 2018. PMID: 29373617 Review. - The impact of carotid artery stenting on cognitive function in patients with extracranial carotid artery stenosis.
Antonopoulos CN, Kakisis JD, Sfyroeras GS, Moulakakis KG, Kallinis A, Giannakopoulos T, Liapis CD. Antonopoulos CN, et al. Ann Vasc Surg. 2015 Apr;29(3):457-69. doi: 10.1016/j.avsg.2014.10.024. Epub 2015 Jan 13. Ann Vasc Surg. 2015. PMID: 25591487 Review.
Cited by
- Insulin Resistance at the Crossroad of Alzheimer Disease Pathology: A Review.
Berlanga-Acosta J, Guillén-Nieto G, Rodríguez-Rodríguez N, Bringas-Vega ML, García-Del-Barco-Herrera D, Berlanga-Saez JO, García-Ojalvo A, Valdés-Sosa MJ, Valdés-Sosa PA. Berlanga-Acosta J, et al. Front Endocrinol (Lausanne). 2020 Nov 5;11:560375. doi: 10.3389/fendo.2020.560375. eCollection 2020. Front Endocrinol (Lausanne). 2020. PMID: 33224105 Free PMC article. Review. - Perioperative Neurocognitive Screening Tools for At-Risk Surgical Patients.
Kaustov L, Fleet A, Brenna CTA, Orser BA, Choi S. Kaustov L, et al. Neurol Clin Pract. 2022 Feb;12(1):76-84. doi: 10.1212/CPJ.0000000000001132. Neurol Clin Pract. 2022. PMID: 36157624 Free PMC article. Review. - Risk of dementia and cognitive dysfunction in individuals with diabetes or elevated blood glucose.
Wium-Andersen IK, Rungby J, Jørgensen MB, Sandbæk A, Osler M, Wium-Andersen MK. Wium-Andersen IK, et al. Epidemiol Psychiatr Sci. 2019 Aug 28;29:e43. doi: 10.1017/S2045796019000374. Epidemiol Psychiatr Sci. 2019. PMID: 31455437 Free PMC article. - Nutrition and Cognition in Older Adults With Heart Failure: A Systematic Review.
Stewart MW, Traylor AC, Bratzke LC. Stewart MW, et al. J Gerontol Nurs. 2015 Nov;41(11):50-9. doi: 10.3928/00989134-20151015-06. J Gerontol Nurs. 2015. PMID: 26505248 Free PMC article. Review. - Cognitive function in patients with stable coronary heart disease: Related cerebrovascular and cardiovascular responses.
Gayda M, Gremeaux V, Bherer L, Juneau M, Drigny J, Dupuy O, Lapierre G, Labelle V, Fortier A, Nigam A. Gayda M, et al. PLoS One. 2017 Sep 22;12(9):e0183791. doi: 10.1371/journal.pone.0183791. eCollection 2017. PLoS One. 2017. PMID: 28937981 Free PMC article.
References
- Lopez OL, Jagust WJ, DeKosky ST, et al. Prevalence and classification of mild cognitive impairment in the Cardiovascular Health Study Cognition Study: part 1. Archives of neurology. 2003;60(10):1385–9. - PubMed
- Exalto LG, Whitmer RA, Kappele LJ, Biessels GJ. An update on type 2 diabetes, vascular dementia and Alzheimer’s disease. Experimental gerontology. 2012;47(11):858–64. - PubMed
- Bartnik M, Ryden L, Ferrari R, et al. The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe. The Euro Heart Survey on diabetes and the heart. European heart journal. 2004;25(21):1880–90. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- P30 DK036836/DK/NIDDK NIH HHS/United States
- P50 HL083813/HL/NHLBI NIH HHS/United States
- P30DK036836/DK/NIDDK NIH HHS/United States
- P50HL083813/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical